Upper and lower airway inflammation in severe asthmatics: a guide for a precision biologic treatment
Background and aims: Severe asthma may require the prescription of one of the biologic drugs currently available, using surrogate markers of airway inflammation (serum IgE levels and allergic sensitization for anti-IgE, or blood eosinophils for anti-IL5/IL5R). Our objective: to assess upper and lowe...
Main Authors: | Manuela Latorre, Elena Bacci, Veronica Seccia, Maria Laura Bartoli, Cristina Cardini, Silvana Cianchetti, Ludovica Cristofani, Antonella Di Franco, Mario Miccoli, Ilaria Puxeddu, Alessandro Celi, Pierluigi Paggiaro |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-11-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753466620965151 |
Similar Items
-
Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction
by: Silvana Cianchetti, et al.
Published: (2019-11-01) -
Increase in markers of airway inflammation after ozone exposure can be observed also in stable treated asthmatics with minimal functional response to ozone
by: Dente Federico L, et al.
Published: (2010-01-01) -
Comorbidities are associated with different features of severe asthma
by: Federica Novelli, et al.
Published: (2018-12-01) -
Divergent effects of Nitric oxide on airway epithelial cell activation
by: Tommaso Neri, et al.
Published: (2010-01-01) -
Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction
by: Alessandro Celi, et al.
Published: (2021-05-01)